Baixar PDF

Outros usuários também visualizaram estes artigos

PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA IN THE MAGNIFY PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE M Coleman; DJ Andorsky; A Yacoub; JM Melear; SR Fanning; KS Kolibaba; F Lansigan; C Reynolds; G Nowakowski; M Gharibo; E Ahn; J Li; MJ Rummel; JP Sharman;
Hematol Transfus Cell Ther. 2021;43 Supl 1:S98
SUBGROUP ANALYSES OF ELDERLY PATIENTS AGED 70 YEARS IN MAGNIFY: A PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA F Lansigan; DJ Andorsky; M Coleman; A Yacoub; JMM Md; SR Fanning; KS Kolibaba; C Reynolds; G Nowakowski; M Gharibo; E Ahn; J Li; MJ Rummel; JP Sharman;
Hematol Transfus Cell Ther. 2021;43 Supl 1:S105-6
RESULTS FROM VERIFY, A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RUSFERTIDE FOR THE TREATMENT OF POLYCYTHEMIA VERA A Yacoub; AT Kuykendall; N Pemmaraju; K Pettit; J Shatzel; A Lucchesi; V García-Guitérrez; S Khanna; A Molina; A Bankar;
Hematol Transfus Cell Ther. 2025;47 Supl 3: